drugset / Trial / NCT05530811
Dexamethasone as Adjuvant to Bupivacaine in Suprazygomatic Maxillary Nerve Block
RandomizedParallel-groupSingle-blindSupportive care
Summary
Postoperative pain score, Faces, Legs, Activity, Cry, Consolability (FLACC) is the primary outcome. The secondary outcomes are the first-time requested analgesia, the number of children required analgesia, the total amount of analgesic requirements during first the 24 hours.
Timeline
- Start
- 2023-04-01
- Primary completion
- 2024-10-01
- Completion
- 2025-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 0.1 mg/kg | Other |
| Comparator | Bupivacaine | Other / unclassified | 0.5 % | Other |